Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFrenkel Topping Regulatory News (FEN)

Share Price Information for Frenkel Topping (FEN)

Share Price is delayed by 15 minutes
Get Live Data
50.00    0.00 (0.00%)
Bid:
49.00
Ask:
51.00
Spread: 2.00 (4.082%)
Market Cap: £61.45m
FEN Live PriceLast checked at - London Stock Exchange

Intraday Frenkel Topping Share Chart

Trading Statement

20 Jan 2014 15:33

RNS Number : 0890Y
Frenkel Topping Group PLC
20 January 2014
 



 

 

Press Release

20 January 2014

 

Frenkel Topping Group plc

 

("Frenkel Topping", "the Company" or, together with its subsidiaries "the Group")

 

Trading Update

 

Frenkel Topping (AIM:FEN), the provider of specialist independent financial advice on the investment of personal injury damages and clinical negligence awards, today releases a trading update ahead of the release of its final results announcement for the year ended 31 December 2013, which is expected towards the end of March 2014.

 

The Company announces that due to an excellent year of new business, its final results for the year ended 31 December 2013 are expected to be ahead of market expectations.

 

During the year the Group exceeded £0.5 billion of Funds in the Investment Management Service. In addition, its best of breed investment solutions have been embedded and well received in the market place, which is expected to result in an increase in gross, operating and net profit margins.

 

David Southworth, Chairman of Frenkel Topping commented: "The Board is pleased to confirm that the Company's results for the full year are expected to be ahead of market expectations. The Group made considerable progress during the year, having successfully prepared for the legal reforms and considerable changes to benefits entitlement which occurred in 2013, as well as growing the Funds in the Investment Management Service to over £0.5 billion."

 

- Ends -

 

For further information please contact:

Frenkel Topping Group Plc

Richard Fraser, Chief Executive

Tel: +44 (0)161 886 8000

Shore Capital

Pascal Keane / Patrick Castle

Tel:+44 (0)20 7408 4090

 

Media enquiries:

Abchurch

Joanne Shears / Jamie Hooper

Tel: +44 (0) 20 7398 7719

Jamie.hooper@abchurch-group.com

www.abchurch-group.com

 

Notes to Editors:

 

About Frenkel Topping

Frenkel Topping Limited ("Frenkel Topping") is the trading subsidiary of Frenkel Topping Group Plc.

 

Frenkel Topping provides specialist independent financial advice on the investment of personal injury damages and clinical negligence awards. Frenkel Topping offers a complete service for all personal injury claims handlers, lawyers and individual clients, dealing with awards from tens of thousand pounds to multi-million pound cases. Frenkel Topping's expertise includes asset protection, bespoke investment portfolios, analysis of periodical payments, Court of Protection portfolios and provision and setting up of trustee and receivership bank accounts. Frenkel Topping has over £0.5 billion of clients' funds in its investment management service.

 

The Group's strategy is to continue to grow its Funds in Investment Management Services organically and to maintain steady levels of recurring revenues at their current high levels of circa. 70%. The Group's strong market position means that it is well poised for future growth.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTBUGDBIDDBGSG
Date   Source Headline
9th Jan 201412:49 pmRNSNew Director Incentive Scheme
6th Dec 20139:58 amRNSHolding(s) in Company
12th Nov 20133:59 pmRNSHolding(s) in Company
11th Nov 201311:31 amRNSDirector/PDMR Shareholding
26th Sep 20138:51 amRNSHolding(s) in Company
25th Sep 201312:13 pmRNSHolding(s) in Company
6th Sep 20139:26 amRNSHolding(s) in Company
5th Sep 20132:34 pmRNSDirector/PDMR Shareholding
14th Aug 20133:17 pmRNSDirector/PDMR Shareholding - Replacement
14th Aug 20139:44 amRNSDirector/PDMR Shareholding and Group EBT Purchase
6th Aug 20132:28 pmRNSExercise of options
15th Jul 20137:00 amRNSInterim Results
1st Jul 20137:00 amRNSNotice of Interim Results
29th May 201310:42 amRNSResult of AGM
29th May 20139:16 amRNSDirector/PDMR Shareholding
29th May 20137:00 amRNSAGM Statement
21st May 20134:10 pmRNSHolding(s) in Company
17th May 20137:00 amRNSHolding(s) in Company
15th May 20133:56 pmRNSDirector/PDMR Shareholding
9th Apr 20137:00 amRNSPreliminary Results
3rd Apr 20132:57 pmRNSHolding(s) in Company
28th Feb 20137:00 amRNSTotal Voting Rights
12th Feb 20137:00 amRNSAcquisitions of Minority Interests in Subsidiaries
1st Feb 20134:49 pmRNSHolding(s) in Company
1st Feb 20131:54 pmRNSHolding(s) in Company
28th Jan 20137:00 amRNSNotice of Results
16th Jan 20137:00 amRNSTrading Update
30th Nov 20121:26 pmRNSHolding(s) in Company
23rd Oct 201211:23 amRNSDirector's Dealing and Group EBT Share Purchase
4th Oct 20127:00 amRNSFrenkel Topping implements new integrated platform
28th Sep 20127:00 amRNSTotal Voting Rights
10th Sep 201212:53 pmRNSDirector/PDMR Shareholding
29th Aug 201212:00 pmRNSExercise of Options
16th Jul 20127:00 amRNSInterim Results
2nd Jul 20122:07 pmRNSNotice of Interim Results
14th Jun 20126:25 pmRNSDirector/PDMR Shareholding
17th May 201211:55 amRNSResult of AGM
17th May 20127:00 amRNSAGM Statement
4th Apr 20121:42 pmRNSHolding(s) in Company
22nd Mar 20124:52 pmRNSHolding(s) in Company
20th Mar 201210:57 amRNSCalendar for 2011 Final Dividend
20th Mar 20127:00 amRNSFinal Results
22nd Feb 20124:44 pmRNSTrading Statement
12th Jan 20127:00 amRNSTrading Statement
30th Nov 20114:12 pmRNSDirector/PDMR Shareholding
23rd Nov 201111:34 amRNSDirector/PDMR Shareholding
22nd Nov 20113:01 pmRNSEmployee Benefit Trust share purchase
27th Oct 20116:11 pmRNSDirector Shareholding and Holding in Company
20th Sep 20113:41 pmRNSDirector/PDMR Shareholding
6th Sep 201112:41 pmRNSExercise of options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.